Author:
Solish Nowell,Carruthers Jean,Kaufman Joely,Rubio Roman G.,Gross Todd M.,Gallagher Conor J.
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Fonfria E, Maignel J, Lezmi S, Martin V, Splevins A, Shubber S, et al. The expanding therapeutic utility of botulinum neurotoxins. Toxins (Basel). 2018;10(5):208. https://doi.org/10.3390/toxins10050208.
2. Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, et al. Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86(19):1818–26. https://doi.org/10.1212/WNL.0000000000002560.
3. Sundaram H, Signorini M, Liew S, Trindade de Almeida AR, Wu Y, Vieira Braz A, et al. Global aesthetics consensus: botulinum toxin type A–evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complications. Plast Reconstr Surg. 2016;137(3):518e-e529. https://doi.org/10.1097/01.prs.0000475758.63709.23.
4. Allergan. BOTOX (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use prescribing information. 2020. https://media.allergan.com/actavis/actavis/media/allergan-pdf-documents/product-prescribing/20190620-BOTOX-100-and-200-Units-v3-0USPI1145-v2-0MG1145.pdf. Accessed 4 Aug 2021.
5. Ipsen. DYSPORT (abobotulinumtoxinA) for injection, for intramuscular use prescribing information. 2018. https://www.ipsen.com/websites/Ipsen_Online/wp-content/uploads/sites/9/2019/01/21084019/Dysport_Full_Prescribing_Information.pdf. Accessed 1 Mar 2021.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献